During the past decade, Messino Cancer Centers conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 8 clinical trials were completed, i.e. on average, 22.9% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 6 clinical trials were completed. i.e. 26.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Messino Cancer Centers" #1 sponsor was "National Cancer Institute (NCI)" with 22 trials, followed by "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored and "Denovo Biopharma LLC" with 1 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Messino Cancer Centers" #1 collaborator was "NRG Oncology" with 5 trials as a collaborator, "National Cancer Institute (NCI)" with 4 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "BeiGene" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Messino Cancer Centers" are "Chronic Lymphocytic Leukemia" (3 trials), "Recurrent Breast Carcinoma" (3 trials), "Small Lymphocytic Lymphoma" (3 trials), "Stage III Breast Cancer AJCC v7" (3 trials) and "Breast Ductal Carcinoma In Situ" (2 trials). Many other conditions were trialed in "Messino Cancer Centers" in a lesser frequency.

Most popular intervention types in "Messino Cancer Centers" are "Drug" (34 trials), "Other" (24 trials), "Biological" (16 trials), "Procedure" (13 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (13 trials), "Laboratory Biomarker Analysis" (11 trials), "Biospecimen Collection" (7 trials), "Computed Tomography" (7 trials) and "Placebo Administration" (6 trials). Other intervention names were less common.

The vast majority of trials in "Messino Cancer Centers" are 37 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Messino Cancer Centers". undefined are not yet recruiting, 19 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Messino Cancer Centers, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Messino Cancer Centers, 2 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".